Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder

NCT: NCT07640945 · NOT_YET_RECRUITING

NCT IDNCT07640945
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-02
SponsorCentral South University (OTHER)
First posted
Last updated

Brief Summary

Generalized Anxiety Disorder (GAD) is a common psychiatric disorder associated with persistent anxiety, functional impairment, and incomplete response to existing treatments. Although transcranial magnetic stimulation (TMS) has shown therapeutic potential in anxiety disorders, conventional treatment schedules often require several weeks and may not provide sufficiently rapid symptom relief. This study aims to evaluate the efficacy and safety of precision-targeted accelerated continuous theta-burst stimulation (cTBS) guided by individualized functional connectivity between the intraparietal sulcus (IPS) and the amygdala in patients with GAD.

Frequently Asked Questions

What is MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder?

MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder is a clinical trial registered under NCT07640945. Current status: NOT_YET_RECRUITING.

What is the status of NCT07640945?

The current status of NCT07640945 (MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder) is: NOT_YET_RECRUITING.

When did MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder start?

MRI-Guided Accelerated cTBS for Generalized Anxiety Disorder started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.